Tri-Segmented Arenavirus Genome Layout for Stable Transgene Expression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing arenaviruses with rearranged open reading frames (ORFs) tend to recombine into replication-competent bi-segmented particles, leading to attenuated growth and loss of transgene expression, posing challenges for stable genetic manipulation and vaccine development.

Innovation Solution

Engineering arenavirus genomic segments to carry ORFs in positions other than their wild-type positions, resulting in tri-segmented particles that maintain genetic stability and ensure lasting transgene expression, using arenavirus untranslated regions (UTRs) to control ORF expression.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If arenavirus ORFs are rearranged to create tri-segmented particles, then genetic stability and transgene expression are improved, but device complexity and manufacturing difficulty increase

Engineering Contradiction:
Improvegenetic stabilityVSAvoidgenome structure complexity
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The arenavirus genome is divided into three separate segments (L1, L2, and S) instead of the conventional two segments. This segmentation prevents recombination into replication-competent bi-segmented forms while maintaining viral functionality and enabling sustained transgene expression. Each segment contains specific ORFs in non-canonical positions, with L1 and L2 segments containing duplicated ORFs that cannot properly recombine.

Inventive Principle:
Principle #1Segmentation

2Reliability

If arenavirus ORFs are rearranged to prevent recombination, then reliability of transgene expression is improved, but ease of manufacture deteriorates

Engineering Contradiction:
Improvetransgene expression reliabilityVSAvoidvirus production ease
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The invention changes the fundamental parameters of the arenavirus genome by creating tri-segmented particles with ORFs positioned in non-canonical locations. The L segments contain ORFs in alternative arrangements (e.g., L1 with NP-ORF and L-ORF in opposite orientations, L2 with duplicated ORFs), and the S segment contains GP and NP ORFs. These parameter changes ensure that recombination does not produce replication-competent viruses, thereby guaranteeing reliable and sustained transgene expression without reversion to wild-type configuration.

Inventive Principle:
Principle #35Parameter changes

3Duration of action of moving object

If tri-segmented particles are engineered with ORFs in non-wild-type positions, then duration of transgene expression is extended, but productivity of viral replication is reduced

Engineering Contradiction:
Improvetransgene expression durationVSAvoidviral replication productivity
Core Design Contradiction:
Duration of action of moving objectVSProductivity

Solution Approach 1:

The tri-segmented arenavirus particles exhibit dynamic characteristics where the genome segments remain separate and cannot recombine into replication-competent forms. This dynamic separation ensures that transgene expression continues over extended periods without the virus reverting to a replication-competent state. The duplicated ORFs in L1 and L2 segments are maintained in non-functional arrangements that prevent productive recombination, thereby extending transgene expression duration while limiting viral replication productivity.

Inventive Principle:
Principle #15Dynamics

Data Source

PatentEP3778903B1Tri-segmented arenaviruses as vaccine vectors
Publication Date: 2026.01.14 UNIVERSITY OF GENEVA
  • EP3778903B1 patent drawingFigure 1A~1D
  • EP3778903B1 patent drawingFigure 2A~2C
  • EP3778903B1 patent drawingFigure 3A~3D

AI summary

Provided herein is a modified arenavirus genomic segment, wherein the arenavirus genomic segment is engineered to carry a viral ORF in a position other than the wild-type position of the ORF. Further provided herein is an arenavirus particle comprising the arenavirus genomic segment. A vaccine and a pharmaceutical composition comprising the arenavirus particle are also provided.